Sec Form 13D Filing - Braeden Lichti filing for Elevai Labs, Inc. Common Stock (ELAB) - 2025-03-28

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D



Comment for Type of Reporting Person:
Consists of (i) 1,362 shares of common stock of PMGC Holdings Inc. (the "Common Stock") held by BWL Investments Ltd., a company solely owned and controlled by Mr. Lichti, (ii) 592 shares of Common Stock held by BWL Holdings Ltd., a company solely owned and controlled by Mr. Lichti, (iii) 592 shares of Common Stock held by NorthStrive Fund II LP., a company solely owned and controlled by Mr. Lichti, (iv) 143 shares of Common Stock issuable upon exercise of stock options held by Braeden Lichti, (v) 44 shares of Common Stock issuable upon exercise of a warrant held by BWL Investments Ltd., a company solely owned and controlled by Mr. Lichti. The reported ownership of Common Stock reflects the automatic adjustment of Mr. Lichti's holdings due to a 1-for-200 reverse stock split of the Issuer's Common Stock, effective November 27, 2024, and a 1-for-7 reverse stock split of the Issuer's Common Stock, effective March 10, 2025. Mr. Lichti owns 0.19% of 1,403,734 shares of the Issuer's Common Stock issued and outstanding as of March 26, 2025.


SCHEDULE 13D

 
Braeden Lichti
 
Signature:/s/ Braeden Lichti
Name/Title:Braeden Lichti, Self
Date:03/28/2025
primary_doc.xml